Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a once-weekly subcutaneous injection that requires proper administration technique to maximize absorption and minimize discomfort. Most patients successfully self-inject at home using four primary body locations, each with distinct advantages for needle placement and medication delivery. PlexusDx supplies compounded semaglutide from licensed 503A pharmacies with complete guidance on safe injection practices.

Approved Body Sites for Semaglutide Injection

The abdomen offers the largest injection surface area and remains the most popular site for semaglutide administration. Inject into the fatty tissue below the skin (subcutaneous layer) roughly two inches away from your navel, rotating between left and right sides weekly to prevent lipodystrophy or skin thickening. The abdominal wall has reliable absorption rates and typically causes less bruising than other sites.

The upper arm (back of the triceps) provides a second convenient location, particularly for patients who prefer smaller needles and find it easier to access during travel. Ask a partner or family member to help with arm injections if needle anxiety makes self-administration difficult. Rotating between left and right arms weekly maintains tissue health and consistent medication delivery.

The thigh (upper outer area) represents another approved site with good subcutaneous tissue depth and accessibility. Injecting into the outer thigh allows patients to inject while sitting and reduces the psychological barrier some experience with abdominal injections. Alternate legs weekly and space injections at least one inch apart.

Step-by-Step Home Injection Technique

Begin by washing your hands thoroughly with soap and water, then inspect your semaglutide pen or vial for cloudiness, discoloration, or visible particles—discard any compromised medication. Allow the medication to reach room temperature for 15 to 30 minutes before injection, as cold medication may cause more injection-site discomfort. Clean your chosen injection site with an alcohol swab in a circular motion and let it dry completely before proceeding.

Pinch a fold of skin at your injection site between thumb and forefinger, creating a tent of subcutaneous tissue beneath the dermis. Insert the needle at a 45 to 90-degree angle, depending on your body composition and needle length, then release the skin fold and inject slowly over 3 to 5 seconds. Withdraw the needle at the same angle and apply gentle pressure with a clean cotton ball or gauze pad for 10 seconds without massaging the area.

Dispose of needles in an FDA-approved sharps container rather than household trash, and store your medication in the refrigerator at 36 to 46 degrees Fahrenheit or at room temperature below 86 degrees for up to 56 days when using certain pens. Record your injection date, site, and any reactions in a patient log to help track side effects and identify patterns. Rotate injection sites systematically—if you start with the abdomen week one, move to the arm week two, thigh week three, and buttocks week four before returning to the abdomen.

Common Injection Site Reactions and How to Prevent Them

Redness, swelling, and mild bruising at injection sites affect approximately 30% of semaglutide patients during the first month but typically resolve within 2 to 3 days. These reactions decrease significantly with consistent site rotation and proper injection depth into subcutaneous tissue rather than dermis. If reactions persist beyond one week or spread across multiple injection sites, contact your healthcare provider to rule out infection or allergic response.

Lipodystrophy—localized thickening, hollowing, or induration of tissue—develops when patients repeatedly inject into the same small area without adequate rotation. Prevent this complication by spacing injections at least one inch apart and systematically rotating between the four approved body sites each week. If you notice skin changes at previous injection sites, allow that area to rest for at least four weeks before returning to it.

Injection-site pain and anxiety affect patient adherence and can be minimized through several strategies: use the thinnest available needle gauge, allow cold medication to warm to room temperature, ensure your skin is fully dry after alcohol cleansing, and practice deep breathing during needle insertion. Some patients find applying ice to the site for 30 seconds before injection reduces needle sensation, while others prefer heat after injection to improve blood flow and reduce localized soreness.

PlexusDx Semaglutide Delivery and Support

PlexusDx delivers compounded semaglutide injections directly to your home, with treatment starting at $149 per month across all commitment tiers—your dose may need to go up, but your price won't. Each prescription comes from licensed 503A compounding pharmacies that follow strict quality and sterility standards, with detailed injection instruction sheets included in every shipment. PlexusDx serves all 50 states without requiring insurance coverage or monthly membership fees.

Patients can use HSA and FSA accounts to cover PlexusDx semaglutide therapy, reducing out-of-pocket medication costs. For maximum personalization, the Precision Peptide Genetic Test ($99 add-on after your first month) identifies how your unique genetics influence GLP-1 receptor sensitivity, FTO pathways, and other peptide responses across 14 pathways and 49 peptides. This test helps PlexusDx tailor your therapy by revealing your natural predisposition to respond to semaglutide and predicting optimal dosing trajectories based on your genetic makeup.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide into muscle tissue instead of fat?

No—semaglutide must be injected subcutaneously (into the fatty layer beneath skin) for proper absorption and efficacy. Intramuscular injection changes medication absorption rates unpredictably and increases side effects. Always pinch the skin to create a fold and inject at 45 to 90 degrees into subcutaneous tissue only.

How do I know if I'm injecting into the right depth?

The needle should penetrate the outer skin layer (dermis) and deposit medication in the fatty subcutaneous tissue below. If you see blood or experience sharp pain, you may have hit a blood vessel—withdraw, apply pressure, and try a different site. Most semaglutide needles are designed for subcutaneous use, so following proper pinching and angle technique ensures correct depth.

What if I'm anxious about self-injecting semaglutide at home?

PlexusDx includes comprehensive injection guidance with every shipment, and many patients find anxiety decreases after the first two to three injections. Ask a family member or partner to observe your first injection, use the thinnest available needle, and consider numbing the site with ice for 30 seconds before injection. If anxiety persists, discuss alternative formulations like oral semaglutide with your PlexusDx provider.

How often should I rotate injection sites to prevent complications?

Rotate systematically between abdomen, upper arm, thigh, and buttocks each week, spacing injections at least one inch apart within each site. This prevents lipodystrophy and maintains consistent medication absorption across weeks and months. If you develop redness or swelling, allow that specific area at least one to two weeks of rest before using it again.

Can the Precision Peptide Genetic Test predict my injection site sensitivity?

The Precision Peptide Genetic Test identifies genetic variants in GLP1R, GIPR, FTO, and MC4R that influence how your body responds to semaglutide therapy, though it doesn't directly predict injection-site reactions. Your unique genetic profile helps PlexusDx optimize your starting dose and escalation plan, reducing overall side effects including injection-site discomfort during dose titration.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves